Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Environmental Research and Public Health|July 27, 2022
Mifepristone (RU-486<sup>®</sup>) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health CareYi-Ping Hsieh, Yun-Ju Wang, Ling-Yi Feng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2024
Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use-Associated Infective EndocarditisMary C Figgatt, David L Rosen, Vivian H Chu, et al.
The American Journal of Orthopsychiatry|May 1, 2020
Hazardous drinking, alcohol use disorders, and need for treatment among Pacific Islander young adultsAndrew M Subica, Erick Guerrero, Nia Aitaoto, et al.
Contemporary Clinical Trials|July 23, 2016
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) toolLi-Tzy Wu, Jennifer McNeely, Geetha A Subramaniam, et al.
Annals of Emergency Medicine|March 20, 2012
Alcohol and drug use disorders among adults in emergency department settings in the United StatesLi-Tzy Wu, Marvin S Swartz, Zunyou Wu, et al.
Journal of Clinical Psychopharmacology|September 18, 2007
Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependencePaolo Mannelli, Ashwin A Patkar, Kathleen Peindl, et al.
Addiction Biology|August 22, 2008
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trialPaolo Mannelli, Ashwin A Patkar, Kathi Peindl, et al.
Pageof 19